Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

NCT01333501

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Novartis Investigative Site Alzenau in Unterfranken, Germany
  • Novartis Investigative Site Bamberg, Germany
  • Novartis Investigative Site Leipzig, Germany
  • Novartis Investigative Site Würzburg, Germany
View all 26 locations
View Trial Details
Completed

Natalizumab Re-Initiation of Dosing

NCT00306592

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
View all 63 locations
View Trial Details
Completed

An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis

NCT01462318

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Centennial, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Lake Barrington, Illinois, United States
  • Research Site Lexington, Kentucky, United States
View all 19 locations
View Trial Details
Completed

Rebif® Rebidose® Versus Rebiject II® Ease-of-Use

NCT02019550

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Research site Cullman, Alabama, United States
  • Research Site Tuscon, Arizona, United States
  • Research Site Newport Beach, California, United States
  • Research site Fort Collins, Colorado, United States
View all 21 locations
View Trial Details

Related conditions